Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Charles River Lbrtrs ntrntl In - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CRL
New York
8731
https://www.criver.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Charles River Lbrtrs ntrntl In
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
- Mar 27th, 2024 12:00 pm
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
- Mar 26th, 2024 1:39 pm
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
- Mar 23rd, 2024 1:00 pm
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
- Mar 21st, 2024 12:00 pm
Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report?
- Mar 15th, 2024 3:30 pm
Charles River (CRL) Extends Gene Therapy Offering With New Pact
- Mar 15th, 2024 2:30 pm
Here's Why You Should Retain Charles River (CRL) Stock Now
- Mar 14th, 2024 1:46 pm
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
- Mar 14th, 2024 12:00 pm
Charles River Laboratories to Present at Barclays Global Healthcare Conference
- Mar 12th, 2024 12:00 pm
Insider Sell: CSVP & Chief Accounting Officer Michael Knell Sells Shares of Charles River ...
- Mar 12th, 2024 4:11 am
Calculating The Fair Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
- Mar 7th, 2024 5:45 pm
The Top 3 Healthcare Stocks to Buy in March 2024
- Mar 7th, 2024 5:27 pm
Insider Sell: EVP & Chief People Officer Victoria Creamer Sells 5,000 Shares of Charles ...
- Mar 2nd, 2024 4:32 am
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
- Feb 29th, 2024 7:00 am
Charles River (CRL) Forges Collaboration With Wheeler Bio
- Feb 26th, 2024 1:41 pm
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
- Feb 22nd, 2024 2:50 pm
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
- Feb 21st, 2024 3:40 pm
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
- Feb 21st, 2024 1:00 pm
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
- Feb 20th, 2024 1:08 pm
Charles River Laboratories International Full Year 2023 Earnings: EPS Beats Expectations
- Feb 16th, 2024 11:44 am
Scroll